Peptide-Based Topical System Delivers Finasteride for Hair Growth with 40-Fold Less Drug
A carrier-free peptide delivery system applied topically matched or exceeded minoxidil 5% for hair regrowth while using roughly 40 times less finasteride than the standard oral dose.
Quick Facts
What This Study Found
Peptide-finasteride nanocomplexes promoted hair regeneration comparable to 5% minoxidil in vivo, using approximately 40-fold less finasteride than the standard oral dose.
Key Numbers
How They Did This
Preclinical study using cell viability assays, in vivo murine hair regrowth models, and biochemical analysis of follicle cycling.
Why This Research Matters
Finasteride oral side effects limit its use for hair loss. This topical approach could retain efficacy while dramatically reducing systemic drug exposure, potentially making finasteride safer for long-term use.
The Bigger Picture
This carrier-free peptide platform could be adapted for topical delivery of other drugs beyond hair loss, offering a versatile approach to reducing systemic side effects in dermatology.
What This Study Doesn't Tell Us
Preclinical (mouse model) only; human clinical trials are needed. Differences in human vs. murine hair biology may affect translation.
Questions This Raises
- ?Will this formulation show comparable efficacy in human clinical trials?
- ?What is the long-term safety profile of the skin-penetrating peptide itself?
- ?Could this platform deliver other hair loss treatments like dutasteride or minoxidil more effectively?
Trust & Context
- Key Stat:
- ~40x less drug Topical peptide-finasteride nanocomplexes matched minoxidil efficacy with dramatically reduced drug exposure
- Evidence Grade:
- Preclinical study with strong in vivo results in mice, but no human data yet.
- Study Age:
- Published in 2026.
- Original Title:
- Topical Carrier-Free Delivery of Finasteride and Peptides for Enhanced Hair Growth.
- Published In:
- Biomacromolecules, 27(2), 1300-1309 (2026)
- Authors:
- Chung, Won Young, Kim, Ji-Eun(2), Lee, Jae Yun, Kim, Suin, Jeong, Woo-Jin
- Database ID:
- RPEP-15044
Evidence Hierarchy
Frequently Asked Questions
How does this peptide hair treatment work?
A skin-penetrating peptide wraps around finasteride to form tiny nanocomplexes that penetrate the scalp and deliver the drug directly to hair follicles. The peptide itself also reduces inflammation, giving a dual therapeutic effect.
Is this available for hair loss treatment now?
No, this is a preclinical study in mice. Human clinical trials are needed before this could become a commercial product.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15044APA
Chung, Won Young; Kim, Ji-Eun; Lee, Jae Yun; Kim, Suin; Jeong, Woo-Jin. (2026). Topical Carrier-Free Delivery of Finasteride and Peptides for Enhanced Hair Growth.. Biomacromolecules, 27(2), 1300-1309. https://doi.org/10.1021/acs.biomac.5c01874
MLA
Chung, Won Young, et al. "Topical Carrier-Free Delivery of Finasteride and Peptides for Enhanced Hair Growth.." Biomacromolecules, 2026. https://doi.org/10.1021/acs.biomac.5c01874
RethinkPeptides
RethinkPeptides Research Database. "Topical Carrier-Free Delivery of Finasteride and Peptides fo..." RPEP-15044. Retrieved from https://rethinkpeptides.com/research/chung-2026-topical-carrierfree-delivery-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.